World-leading mass spectrometry instrument manufacturer contributing high-precision analytical platforms to EU research in geoscience, proteomics, and industrial metrology.
Thermo Fisher Scientific (Bremen) is the mass spectrometry division of the global Thermo Fisher Scientific corporation, developing and manufacturing high-precision analytical instruments — particularly isotope ratio mass spectrometers (IRMS) and high-resolution mass spectrometers used in geochemistry, proteomics, and industrial metrology. In H2020 projects, they contribute advanced instrumentation and analytical expertise, enabling research teams to perform isotopic analysis, protein characterization, and trace element measurements at the frontier of detection sensitivity. Their Bremen facility is recognized as a world-leading center for mass spectrometry instrument development.
Four projects (BASE-LiNE Earth, COSMOKEMS, NONUNE, and partly MASSTRPLAN) rely on their isotope analysis instrumentation for geochemistry, cosmochemistry, and paleoclimate research.
MSmed, MASSTRPLAN, TopSpec, and PROTrEIN all center on mass spectrometry applications for protein analysis, from systems medicine to antibody profiling.
MADEin4 applies their measurement expertise to digitized manufacturing quality control and Industry 4.0 inspection platforms.
TEMPERA explores mass spectrometry for analyzing ancient proteins in cultural heritage materials — a niche but growing application area.
In their early H2020 participation (2015–2018), Thermo Fisher Bremen focused heavily on geoscience instrumentation — isotope ratio analysis of carbonates, brachiopod shells, meteorites, and trace elements in seawater. From 2019 onward, their portfolio diversified significantly into life sciences (antibody profiling, computational proteomics, ancient proteins) and industrial applications (smart manufacturing metrology). This shift mirrors the broader industry trend of mass spectrometry expanding from its traditional geochemistry stronghold into biomedical and industrial quality control markets.
They are broadening from pure geoscience instrumentation toward biomedical proteomics and digitized industrial measurement, suggesting future collaborations should pitch applications in life sciences or smart manufacturing.
Thermo Fisher Bremen exclusively participates as a partner — never as coordinator — which is typical for a large instrument manufacturer contributing equipment and analytical know-how to researcher-led consortia. With 120 unique partners across 22 countries, they operate as a widely connected infrastructure node rather than a project driver. Their involvement in multiple Marie Skłodowska-Curie training networks (3 MSCA-ITN projects) signals a commitment to hosting early-stage researchers and providing industry training placements.
An extensively networked industry partner with 120 unique collaborators across 22 countries, reflecting their role as a go-to instrument provider that academic consortia across Europe seek out for analytical capability and researcher training.
As the mass spectrometry division of the world's largest scientific instrumentation company, they bring production-grade analytical instruments directly into research consortia — not prototypes, but the same platforms used globally in commercial labs. This makes them uniquely valuable for projects that need to demonstrate real-world applicability and technology transfer. Few other H2020 participants can simultaneously train PhD researchers on cutting-edge proteomics AND supply the instruments those researchers will use throughout their careers.
